Sunil Dhawan

1.5k total citations
41 papers, 784 citations indexed

About

Sunil Dhawan is a scholar working on Dermatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Sunil Dhawan has authored 41 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Dermatology, 14 papers in Epidemiology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Sunil Dhawan's work include Acne and Rosacea Treatments and Effects (17 papers), Dermatology and Skin Diseases (14 papers) and Dermatologic Treatments and Research (7 papers). Sunil Dhawan is often cited by papers focused on Acne and Rosacea Treatments and Effects (17 papers), Dermatology and Skin Diseases (14 papers) and Dermatologic Treatments and Research (7 papers). Sunil Dhawan collaborates with scholars based in United States, Spain and France. Sunil Dhawan's co-authors include Ronald G. Wheeland, Zoé Kececioglu Draelos, Emil Tanghetti, Robert Poppiti, Linda Stein Gold, Jamie S. Barkin, F. Jiménez‐Acosta, Jonathan Weiss, Abhirup Mandal and Samir Mitragotri and has published in prestigious journals such as Science Advances, Journal of the American Academy of Dermatology and Plastic & Reconstructive Surgery.

In The Last Decade

Sunil Dhawan

41 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sunil Dhawan United States 17 483 163 140 92 84 41 784
Mariateresa Rossi Italy 18 428 0.9× 236 1.4× 76 0.5× 184 2.0× 57 0.7× 85 941
Angela Moore United States 18 715 1.5× 300 1.8× 132 0.9× 261 2.8× 39 0.5× 72 1.3k
Yanhua Liang China 19 407 0.8× 127 0.8× 108 0.8× 285 3.1× 32 0.4× 67 1.3k
Georgia Avgerinou Greece 15 232 0.5× 118 0.7× 54 0.4× 195 2.1× 41 0.5× 33 574
D. Morgado‐Carrasco Spain 14 353 0.7× 105 0.6× 105 0.8× 49 0.5× 21 0.3× 139 625
Yuehua Liu China 15 208 0.4× 136 0.8× 90 0.6× 91 1.0× 13 0.2× 97 710
Nordwig S. Tomi Germany 16 538 1.1× 82 0.5× 50 0.4× 237 2.6× 219 2.6× 26 815
Romana Čeović Croatia 14 378 0.8× 106 0.7× 47 0.3× 205 2.2× 40 0.5× 53 632
Jean‐Jacques Guilhou France 17 196 0.4× 114 0.7× 132 0.9× 196 2.1× 18 0.2× 39 716
Francesca Bruni Italy 15 392 0.8× 240 1.5× 37 0.3× 88 1.0× 196 2.3× 75 892

Countries citing papers authored by Sunil Dhawan

Since Specialization
Citations

This map shows the geographic impact of Sunil Dhawan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Dhawan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Dhawan more than expected).

Fields of papers citing papers by Sunil Dhawan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunil Dhawan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Dhawan. The network helps show where Sunil Dhawan may publish in the future.

Co-authorship network of co-authors of Sunil Dhawan

This figure shows the co-authorship network connecting the top 25 collaborators of Sunil Dhawan. A scholar is included among the top collaborators of Sunil Dhawan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunil Dhawan. Sunil Dhawan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sarin, Kavita Y., Mark Bradshaw, Steven Kempers, et al.. (2024). Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1. Science Advances. 10(18). eadk4946–eadk4946. 4 indexed citations
3.
Schleicher, Stephen M., Angela Moore, Elyse S. Rafal, et al.. (2023). Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study. Dermatology and Therapy. 13(12). 3085–3096. 10 indexed citations
4.
Pinter, Andreas, Linda Stein Gold, Adam Reich, et al.. (2022). A novel, fixed‐dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30thEADV Congress 2021. Journal of the European Academy of Dermatology and Venereology. 37(S1). 14–19. 4 indexed citations
5.
Sidbury, Robert, Sady Alpizar, Vivian Laquer, et al.. (2022). Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents. Dermatology and Therapy. 12(3). 631–642. 29 indexed citations
6.
Gold, Linda Stein, et al.. (2021). A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream. Journal of Drugs in Dermatology. 20(4). 420–425. 16 indexed citations
7.
Ko, Justin, et al.. (2020). Clinical translation of choline and geranic acid deep eutectic solvent. Bioengineering & Translational Medicine. 6(2). e10191–e10191. 46 indexed citations
8.
Fabi, Sabrina G., Joel L. Cohen, Lawrence J. Green, et al.. (2020). DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study. Dermatologic Surgery. 47(1). 48–54. 21 indexed citations
10.
Gold, Linda Stein, Sunil Dhawan, Jonathan Weiss, et al.. (2018). A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies. Journal of the American Academy of Dermatology. 80(1). 168–177. 38 indexed citations
12.
Dhawan, Sunil, et al.. (2013). Clindamycin phosphate 1.2%-benzoyl peroxide (5% or 2.5%) plus tazarotene cream 0.1% for the treatment of acne.. PubMed. 91(2). 99–104. 7 indexed citations
13.
Tanghetti, Emil, Sunil Dhawan, Lawrence Green, et al.. (2010). Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.. PubMed. 9(5). 549–58. 28 indexed citations
14.
Dhawan, Sunil. (2009). Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.. PubMed. 83(5). 265–72. 15 indexed citations
15.
Dhawan, Sunil, et al.. (2005). Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis. Journal of the American Academy of Dermatology. 52(3). P196–P196. 6 indexed citations
16.
Dhawan, Sunil. (1991). Tender nodules on the legs. Subcutaneous fat necrosis; associated pancreatitis. Archives of Dermatology. 127(2). 249–249. 3 indexed citations
17.
Dhawan, Sunil, et al.. (1990). Apocrine Adenocarcinoma: Case Report and Review of the Literature. The Journal of Dermatologic Surgery and Oncology. 16(5). 468–470. 28 indexed citations
18.
Dhawan, Sunil. (1990). Lentigo maligna. The use of rush permanent sections in therapy. Archives of Dermatology. 126(7). 928–930. 72 indexed citations
19.
Dhawan, Sunil, et al.. (1990). Cutaneous Periarteritis Nodosa. International Journal of Dermatology. 29(9). 611–615. 15 indexed citations
20.
Dhawan, Sunil, et al.. (1989). Lichen Planus and Ulcerative Colitis— Is There a Relationship?. International Journal of Dermatology. 28(8). 534–534. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026